Rock Springs Capital Management LP 13D/13G Filings for Travere Therapeutics, Inc. (TVTX)

Rock Springs Capital Management LP 13D and 13G filings for Travere Therapeutics, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime
Transaction
Date
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportView
2024-05-01
4:11 pm
Purchase
2024-04-2513GTravere Therapeutics, Inc.
TVTX
Rock Springs Capital Management LP4,411,983
5.790%
4,411,983increase
(New Position)
Filing